Wednesday, August 11, 2021

August 11, 2021 Cancer Myths

This month we came together to discuss Cancer Myths. Twenty-six participants joined us for this important discussion. You may find analytics here and a transcript here

Here is a sample of the responses to our topic questions. 

T1: For you, what makes something a cancer myth? Is it strictly false information or is it something more?

  • I see the term "cancer myth" as a widely held belief about cancer. It could be true, false, misleading or anywhere along the spectrum. For me, it is a vague idea that I haven't really looked into the facts of
  • I think of it as misinformation that for whatever reason has persisted through time.
  • Sometimes people make generalizations ('cancer myths') about cancer, cancer treatments or cancer outcomes - but every cancer is different and every patient has an individual experience.
  • I think of cancer myths as outdated information or false beliefs that people have regarding cancer.
  • It may also be an assumption about the disease, or its treatments, that are taken for granted based up conventional wisdom, rather than evidence. When passed down by attendings to trainees, we called it #oncolore in my residency

T2: What are some cancer myths that you grew up with? What are some you have encountered as you've been impacted by cancer or worked with cancer patients? (re: causes/what happens during treatment/about emerging treatments/other)

  • Thinking back on my dad's cancer, I remember people talking about this idea that once you have surgery and expose it to air, you've allowed the cancer to spread and the end comes more quickly
  • People thinking there is a cure for cancer and it’s being hidden from us, sigh 😣🙄. Cancer isn’t one disease. People don’t realize it’s many diseases.
  • “Cancer is a death sentence”, “Sugar fuels cancer”, “You are too young for cancer”, to name a few.
  • I think “cancer = death sentence” is a belief/response that can be important to unpack and surround w/the individual facts at hand. Some cancers do have little progress - others certainly not as much as we would like - but there are ways to provide hope along w/info
  • A cancer myth I still occasionally hear is "you can only inherit female cancer risks from mom" ... We all inherit DNA from both mom and dad, hereditary cancer risks included! Both sides of family health history are important #gyncsm #FamilyHealthHistory #GeneticsMyths
  • Growing up - The myth that only old people got cancer. Most recently - The myth that my HPV cancer was directly my fault. #gyncsm

T3: What are some cancer myths that come up around nutrition/diet? Why do you think there is so much conflicting information in this area?

  • the top myth to me is - People who have cancer shouldn't eat sugar, since sugar makes cancer to grow faster. All cells, including cancer cells, depend on blood sugar (glucose) for energy. Giving more sugar to cancer cells doesn't make them grow faster.
  • And artificial sugars too. So no sweets for anyone lol. #gyncsm
  • I think people want to believe that you have some control over whether you get cancer so thinking that if you eat healthy, limit sugar, and exercise, you will be safe which is not always true
  • Agree - The risk of focusing on areas we can "control" is the inevitable opposite, that when something out of our control happens, there is shame/blame... Feels similar to fad diets and other trends that seem to just make people feel bad about their bodies
T4: Are there cancer myths specific to gynecologic cancers? Is there information you learned about a gyn cancer that you now know is wrong?
  • Maybe not a myth, but there is a lack of basic female anatomy knowledge and also many do think the pap covers “everything down there” vs mainly cervical cancer.
  • In the #sarcoma world, some women assume a PAP smear will catch their cancer. Not necessarily.
  • There are absolutely myths to GYN cancers. One is that cervical cancer is the “easy” cancer, that it is just bad cells from a Pap test when in reality it is much, much more involved.
  • that the Gardasil vaccine will cause fertility issues or other catastrophic problems.
T5: What are some tips for handling cancer myths and responding (or not) when you encounter them - both in-person and online?
  • Tell people to fact check and look for information that is factual and not hearsay. As frustrating as it is at times, some people just can’t hear you.
  • I try to educate in a calm manner to dispel the belief. Can be quite difficult with some people though. It’s important to remember you may not change their mind about some things and to stay composed
  • Very situational - have to adapt to the person and setting. First step I find helpful is active listening and clarifying where the perspective/myth comes from.
  • will ask the person to share the research that backs their statement. Then I share a reliable source or journal article that dispels the myth.
  • I often give people studies or quote experts. But I try to be diplomatic, unless I think the person is making money or hurting people with myths.
  •  Dispelling myths can take a lot of time and energy. And it is okay to not always be up for that. When we can interact one on one and ask questions IF they are open to a discussion that is where to start.
  • Meet people where they’re at - sometimes that’s really hard. Sometimes they are not taught what we already know. Clarify and ask questions to understand. Have a conversation. Share your story and some reliable resources for them to check out.
  • There is a ton of attention and research in health communication and combatting misinformation with ~everything~ going on...I look to experts in that space for ideas and approaches to build trust and communicate evidence clearly
  • I get an alert from Pubmed on new research for #leiomyosarcoma, including gyn LMS. I read experts online & attend #sarcoma conferences when I can afford them. 
T6: What are your go-to sources for reliable information about cancer? For gynecologic cancers specifically?

We look forward to you joining us at the next #gyncsm chat on Wednesday, September 8, 2021 at 8pm ET when we’ll discuss Genetic Testing and Gyn Cancers. We’ll also be asking our participants to fill out a survey to help us improve the #gyncsm community. 

See you in September for Gyn Cancer Awareness Month! 

Dee and Christina


 

Sunday, August 8, 2021

Cancer Myths #gyncsm Chat August 11, 2021


Patients and caregivers may hear from family and friends or see advice and information both online and in print about what causes cancer, cancer treatments and risk reduction. Some of that advice is good but some is inaccurate and others are false - yet the information continues to spread. We invite you to join us on Wednesday, August 11, 2021 at 8pm ET (7 CT, 5 PT) as the #gyncsm community comes together to discuss Cancer Myths and shed some light on where you can go to find reliable and accurate information.

We'll use the following Topic Questions (T#:) to guide our discussion:

T1: For you, what makes something a cancer myth? Is it strictly false information or is it something more?

T2: What are some cancer myths that you grew up with? What are some you have encountered as you've been impacted by cancer or worked with cancer patients? (re: causes/what happens during treatment/about emerging treatments/other)

T3: What are some cancer myths that come up around nutrition/diet? Why do you think there is so much conflicting information in this area?

T4: Are there cancer myths specific to gynecologic cancers? Is there information you learned about a gyn cancer that you now know is wrong?

T5: What are some tips for handling cancer myths and responding (or not) when you encounter them - both in-person and online?

T6: What are your go-to sources for reliable information about cancer? For gynecologic cancers specifically?

 

In preparation for our chat feel free to read this article from the Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/cancer/in-depth/cancer-causes/art-20044714  . 

We look forward to seeing you on Wednesday, August 11th. 

Dee and Christina



Wednesday, June 9, 2021

June 9, 2021 Gyn Cancer Research News - #SGOmtg & #ASCO21

This month we discussed the latest research news from the 2021 SGO Annual Meeting and the 2021 ASCO Annual Meeting . Both meetings were once again held virtually due to the Covid -19 pandemic. 

Twenty-two participants discussed a variety of research studies presented at the two meetings. You may find the complete transcript here and the analytics here

Here are some highlighted answers to our questions. 

T1: 
What #SGOMtg presentations did you personally find of most interest?
Anything practice-changing to note?
T2: 
There was a session at #SGOmtg entitled "Time to Return to the Drawing Board: Learning From Negative Trials." 
What are "negative" trials and what are some key take-aways?  
  • T2 I think hearing about treatments that are tried yet don't give the results the researchers expect are still valuable to hear about. 
  • T2 hard to hear about Negative trials. We learn what not to do; however, it’s disheartening for those in treatment.owed general ovarian screening over time not effective. Hard to learn but glad for these studies. 
  • T2 #SGOMtg Phase II Durvalumab (anti-PDL1)& Tremelimumab (anti-CTLA4) Administered in Combo versus Sequentially for the Treatment of Recurrent HGSOC No diff between arms in PFS  - Clear cell histology should be examined
  • In #sarcoma, the olaratumab trial failed to reach its goals. But it did spur a lot of thinking on trial design.
T3: 
Which #ASCO21 studies do you think may be of most interest to patients?
  • ASCO Abstracts link https://t.co/PlP2JFRsQZ ] #gyncsm
  • T3- definitely a theme of more is not always better. Longer duration of bevacizumab in upfront maintenance did not improve survival in #OvarianCancer 
  • From #ASCO21 I saw diversity and patient voice being highlighted in what seemed to be genuine ways. Long way to go but nice to see. The study about helping "light up" tumor so it can be removed looked fascinating.
  • We evaluated the wee1 inhibitor adavosertib alone or in combination with olaparib in women w #PARPi resistant #OvarianCancer - we saw activity in both arms including disease shrinkage and disease stabilization for >4 months. Many women have stayed on for >a year! 
  • Pafolacianine Sodium injection (OTL38) agent lit up tumors with an overexpression of folate receptor alpha so surgeon could remove.
  • T3 I was excited about a novel GEM vaccine every 4 weeks as maintenance, 91 patients Gem well tolerated. Benefit for Homologous Recombination proficient patients
  • A3: There were so many negative trials this year! But knowing that interventions cause harm without benefit (adding chemo in cx cancer, immunotherapy to ov cancer) is incredibly important to guide future therapies.  
  • This study by @Carisls was important at #ASCO21 for differentiating uterine #leiomyosarcoma from LMS elsewhere in the body. 
  • At #ASCO21, there was continued discussion on PARP inhibitors for (some) women with uterine #leiomyosarcoma. Also, the addition of temozolomide seemed promising. 

T4: 
What are some of the "hot topics" in gynecologic cancer research currently ( PARPs, cytoreductive surgery, immunotherapy, other)? What is still up for debate that patients/survivors/advocates should be aware of?
  • T4 I’m wanting more patients eligible for trials. We, as advocates, need to question this, particularly when we are on trial teams. 
  • From the plenary session #ASCO21 cervical Cancer study - OUTBACK showed that adjuvant chemotherapy added to standard chemoradiation therapy did not improve survival outcomes for women with locally advanced cervical cancer. 
T5:
Are there recent studies surrounding palliative care, survivorship, and psychosocial research that could help gyn cancer survivors? 
  • Different patients feel differently about scans, tumor markers, surveillance (some patients even like getting pelvic examinations!). What's most important is that communication is good so that you can land on a plan that works for patient and healthcare team. 
  • T5 There is this study by @DrAttai presented at ASCO. - Patient preferences for survivorship care #ASCO21 abstr 12064 w/ @DrN_CancerPCP @subatomicdoc @BZavaletaMD meetinglibrary.asco.org/record/200314/…
  • #gyncsm - There was an SGO study around neuropathy " Lauren Thomaier presents Genetic variants predictive of chemotherapy-induced peripheral neuropathy symptoms in gynecologic cancer survivors at #SGOMtg Fantastic work to identify patients most at risk of CIPN! Very important! "
T6
Both #ASCO21 and #SGOmtg held sessions on disparities in gynecologic cancer care. What was highlighted and how can we work to decrease disparities?
  • T6. Black women are more likely to get uterine sarcomas, compared with other racial/ethnic groups. Sarcomas tend to be more aggressive than endometrial carcinoma. But advocates can't seem to get any help in outreach. 
  • T6 Social Determinants, Not Biology: Time to Reappraise Genetics-Based Theories of Racial/Ethnic Cancer Outcome Disparities #ASCO21 #gyncsm Dr Ford: Biological Association of obesity and cancer. SC case I-95 corridor case study most residents are black, > poverty> Cancer rates
  • The first step is admitting that there is a problem which is why I was so glad to see inequities highlighted. We can ask questions of our healthcare systems, and advocate for our healthcare boardrooms to look like the waiting room... 

T7: 
For remaining time, please feel free to ask questions about or highlight other recent research you find of interest. What studies are on the horizon? What areas would you like to see more research?
  • T7: cancer treatment is very expensive. Are there any resources available for those who want to partake in a clinical trial out of state & cannot afford the “room & board” expense? 
  • People need to include #RareCancers in their discussions of #inequity. In gyn #sarcoma, we have less money for research, fewer experts, and less patient support.
  • t7: the research regarding early detection not improving survival is disheartening. I was under the impression that when it is caught early, you have a better chance of long term survival?!
  • I’d like to see more Data related to helping patients access trials outside their cancer center.

Note there will be no #gyncsm chat in July. Save the date for our next chat Wed, Aug 11, 2021 at 8pmET (new time for 2021) when we’ll discuss “Cancer Myths”.

Have a wonderful July!

Dee and Christina


Resources:

 
 

Adjuvant Chemotherapy Fails to Improve PFS and OS in Locally Advanced Cervical Cancer https://www.onclive.com/view/adjuvant-chemotherapy-fails-to-improve-pfs-and-os-in-locally-advanced-cervical-cancer
 
Oncology Nursing Society https://www.ons.org/

Thursday, June 3, 2021

Gyn Cancer Research News - #SGOmtg - #ASCO21

 

It is our pleasure to once again share with our community the latest gyn cancer research news from the SGO Annual Meeting (#SGOmtg) and the ASCO Annual Meeting (#ASCO21). SGO is the Society for Gynecologic Oncology and ASCO is the American Society of Clinical Oncology. Both of their annual meetings were once again held virtually due to the COVID-19 pandemic. 

On June 9, 2021 at 8pm ET (7pm CT, 5PM PT), we invite you to join us as we review some of the latest research and discussions related to gynecologic cancer screening, treatment and research.  We may touch upon secondary surgery, PARP inhibitors, immunotherapy, rare ovarian cancer treatments, early detection and trials with negative results. Each annual meeting has/had several sessions on disparities in the treatment of gyn cancer which we will include in our topic questions. 

We will use these topic questions to guide our discussion

T1: 
What #SGOMtg presentations did you personally find of most interest?
Anything practice-changing to note?

T2: 
There was a session at #SGOmtg entitled "Time to Return to the Drawing Board: Learning From Negative Trials." 
What are "negative" trials and what are some key take-aways?   

T3: 
Which #ASCO21 studies do you think may be of most interest to patients?

T4: 
What are some of the "hot topics" in gynecologic cancer research currently ( PARPs, cytoreductive surgery, immunotherapy, other)? What is still up for debate that patients/survivors/advocates should be aware of?

T5:
Are there recent studies surrounding palliative care, survivorship, and psychosocial research that could help gyn cancer survivors? 

T6: 
Both #ASCO21 and #SGOmtg held sessions on disparities in gynecologic cancer care. What was highlighted and how can we work to decrease disparities?

T7: 
For remaining time, please feel free to ask questions about or highlight other recent research you find of interest. What studies are on the horizon? What areas would you like to see more research?

We look forward to having you join us. 


Dee and Christina

Co-founders #gyncsm Twitter Community

Wednesday, May 12, 2021

May 12, 2021 Risk of Recurrence, Second Cancers, and Other Diseases #gyncsm Chat

The #gyncsm community discussed Risk of Recurrence, Second Cancers, and Other Diseases for those diagnosed with a gynecologic cancer on May 12, 2021. We had twenty-six participants and 1.330 Million impressions - see more analytics here and you may read the transcript here.

Some highlighted Tweets from the chat may be found below each question. You will also find resources listed at the bottom of this post.

T1: What is the risk of recurrence for the main types of gynecologic cancer? Which gyn cancers have the highest recurrence risk?

  • According to @CancerCenter "An est. 35% of patients w/invasive #cervicalcancer develop persistent/recurrent disease following treatment. The recurrent cervical cancer rate is lower for those w/ early-stage disease. Most recurrences occur within 2 years of treatment."
  • The recurrence rate for #ovariancancer is very, very high. It can be hard to talk about with patients - and some don't want to think about it - but it also surprises too many that didn't get an open discussion after initial treatment 
  • Endometrial - recurrence rates for patients with early-stage disease range from 2–15% and reach as high as 50% in advanced stages or in patients with aggressive histologic condition. (70-100%) recurrences occur within 3 years after primary treatment from a 2011 study
  • vulvar cancer - Most recurrence occurs 2 years after treatment in women with inguinal lymph node involvement (32.7%) versus those without (5.1%). #gyncsm
  • Ovarian cancer has the highest recurrence rate overall -85% (occurring in 25% of patients with early-stage disease and >80% of patients with advanced disease.) 
  • There are many variables to consider (tumor stage & subtype, initial treatment, if there were tx breaks). For instance, cervical cancer is more likely to not recur if chemoRT is completed within 8 wks of starting.

T2: What is known about reducing one's risk of recurrence? How are cancer survivors monitored for gyn cancer recurrence?

  • Follow-up care is imperative for preventing recurrence of #cervicalcancer. That includes exams, imaging, and blood work. Exercise and diet may help along with smoking cessation.
  • I have heard that exercise may be beneficial in lowering one’s risk of recurrence
  • There are only so many things that one can control when trying to reduce risk. Some things we know - Find a way to be active that works for you. Stop smoking. Lots unknown. A long-term study in AZ was looking at eating, activity and more for ovarian cancer survivors.
  • While we all want to be in the group that never recurs, I think it's important to let people know the possibility. Nothing stops the shock of actual recurrence, & living in fear is hard - to be sure - but since it's likely with #ovariancancer, facts are important.
  • Survivorship plans are important for continued monitoring after initial diagnosis. The balance is listening to your body and getting things checked out without freaking out.
  • I know I was told very clearly by my first gyn Onc that I had no chance of recurrence, but here I am 4x later. I just hope everyone knows the possibility honestly. #gyncsm
  • T2 monitoring for recurrence: Regular exams; education about symptoms to report; routine imaging not always indicated but depends on individual plan; tumor markers if appropriate. Consuder for Surveillance plan - individual pros and cons/ patients preferences
  • I think survivorship plans are very important its been 10 years since my diagnosis and hardly any of my physicians followed mine because I had endometrial cancer they didn't think it was important after the hysterectomy. If only they knew 
  • Kind of back to preventing recurrence. But what treatment we get initially, if we have a gynonc (or not), & what type of surgery can all matter as well.
T3: Many cancer survivors report that fear of recurrence impacts their survivorship. What are some tips for dealing with the fear of recurrence?
  • We have so many great nuggets of advice on our blog (search for recurrence). A few are "Know your existence," "Own your story," Set boundaries, ask for help, journal it out, and take care of your mental health. https://t.co/25m45zv2WD #cervivor
  • walking my dog always keeps me chill & works for me…. We both enjoy it
  • There are some good resources - videos, podcasts, literature - about dealing with the fear of cancer recurrence because so many experience it. Know you are not alone. #gyncsm one via @CancerDotNet https://t.co/aFzmrUlrrP
  • Latino cancer survivors face a tough journey. Our leader, Dr. Amelie Ramirez of @UTHealthSA, is helping launch a 6-year @theNCI study to find new ways to help Latino cancer survivors heal, recover, and stop cancer from returning!
  • I think the most important thing is to show those of us who LIVE with multiple recurrences and still make a positive impact and have a happy life! It’s tough, but I’m much better off than those frozen in fear! 
  • Incredibly important to address! Any plans for education and surveillance we add as MD we should be recognizing how this creates anxiety! and really should be coupled with how to get resources on coping, normal expected anxiety...
  • Here is the facebook page for Survivor Slimdown https://t.co/tVeEbxSI3N
T4: What are some of the secondary cancers that those with a gynecologic cancer should be concerned about? What is the role of genetics and family history? What about secondary cancers related to treatment?
  •  We can still get cancers that others get. According to @AmericanCancer, #cervicalcancer survivors are at higher risk for: mouth/throat, larynx, anal, vulvar, vaginal, lung, bladder/ureter, stomach, colorectal, pancreas, and acute myeloid leukemia.
  • As we learn more and more about genetics, we learn more about what caners are connected and run in families. Know your family history if you can. See if multi-gene testing is advised as more is known.
  • From @EKing719 in women who have had Hpv-related gyn malignancies there is a risk of anal cancer . Check @FarrahFawcettFN https://t.co/DPVvvpaqzF and at https://t.co/bheTVoAKCu
  • There have been conflicting study results but generally we don't think that radiotherapy increases your risk of rectal cancer for instance. In rare instances, you can develop sarcoma about 10 years after radiotherapy.
  • for basics also making sure survivors keep up with screening depending on phase in cancer care and age re #breastcancerscreening #colorectalcancerscreening #lungcancerscreening // know family history// refer for genetic counseling!!
  • those of us with genetic mutations have to deal with risk of getting yet another cancer and decisions on how to prevent that
  • HNPCC or Lynch Syndrome While HNPCC poses the greatest risk of colorectal cancer, women with HNPCC have about a 12 percent lifetime risk of developing ovarian and a 40-60 percent chance of developing uterine cancer.” https://t.co/QbGQXoXRD5
  • Ran across this while doing chat prep: Meta-analysis and retrospective pharmacovigilance study of MDS and AML in patients receiving PARP inhibitor treatment https://t.co/LXHXHi7T6K
  • It can be heavy to talk about all the additional risks, but like someone said, knowledge can help one deal with the fear and not be blind-sideded if something does come up.
  • Very important point! Important to know for patients who on your medical team can best help quarterback getting appropriate tests scheduled, ordered up to date etc- sometimes gyn onc or med onc or PCP or cancer genetics team . @FacingOurRisk - great resources here!
T5: Are there other physical and mental health conditions that being diagnosed with and treated for gynecologic cancers increase the risk of experiencing?
  • many already have a list of conditions prior to cancer. This just adds to the pile. Can be hard to assess what is causing what.
  • PTSD is often experienced in our community from internal radiation. It may take someone years to process through the emotional toll - as for physical, there are various side effects from lymphedema, infertility, osteoporosis, gastrointestinal issues, etc.
  • For women who were younger who went into surgical menopause due to surgery, this can create many physical & psychological issues.
  • Issues related to sexual function; chronic changes in urinary and GI function after surgery, chemo and or RT.; early referring to physical therapy, urogyn, GI nutrition.... need to ask and talk about even if no easy answers.
  • In my own situation it has increased my anxiety and depression at times especially in regards to my infertility.
  • Confounding this is that the rate of #ovariancancer is higher in those who have had #PTSD prior to diagnosis. And, we know from the #ACEs study, those of us with trauma in childhood have increased risk of many diseases, including cancer.
  • one of my concerns are potential cardiac issues due to cancer treatment combined w surgical menopause.
T6: What impact does having had cancer have on risk for and severity of COVID-19 and other non-cancer related diseases?
  • Most research shows that having cancer increases your risk of severe illness from COVID-19. Other factors include a weakened immune system, older age, and other medical conditions.
  • you can find resources at @GYNCancer site https://t.co/fvRX6dpubK

We end our chats with Today I Learned (TIL) . Here is a TIL from tonight's chat. 
TIL: Hard conversations are... hard. But let's not avoid them. Cancer stories are not all "inspirational/positive" but they are all important and provide so much value. Thanks to all who share their cancer truths.

We look forward to you joining us at the next #gyncsm chat on Wednesday, June 9, at 8pmET (new time for 2021) when we’ll discuss “GYN Cancer Research News” from #SGOMtg and #ASCO21

Dee and Christina
#gyncsm Co-Founders
 

Resources 
@AmericanCancer - Can I Do Anything to Prevent Cancer Recurrence?
https://www.cancer.org/treatment/survivorship-during-and-after-treatment/understanding-recurrence/can-i-do-anything-to-prevent-cancer-recurrence.html

HealthDay - Obesity And Overweight Associated With Increased Risk Of Developing Several Types Of Cancers 

@sloan_kettering MMSKCC - 6 Tips for Managing Fear of Recurrence

Meta-analysis and retrospective pharmacovigilance study of MDS and AML in patients receiving PARP inhibitor treatment  

Ovarian Cancer Patients at Higher Risk for Mental Illness  


@GYNCancer - Covid resources

Post-treatment surveillance and dignosis of recurrence in gynecologic malignancies - SGO recommendations  

American Cancer Society - Second Cancers after Endometrial Cancer 
 
@CancerDotNet - Heart Problems

Thursday, May 6, 2021

Risk of Recurrence, Second Cancers and other Diseases 5/12/21 Chat

 

This month on Wednesday, May 12, 2021 at 8pm ET, the #gyncsm community will discuss Risk of Recurrence, Second Cancers, and Other Diseases among those diagnosed with a gynecologic cancer. 

Recurrence can be a tough subject that sometimes isn't adequately addressed following initial diagnosis and treatment. Yet, depending on the stage at diagnosis, we know that recurrence is an issue survivors deal with frequently. We will discuss what is known about reducing the risk of recurrence, monitoring for recurrence, and addressing the impact of the fear of recurrence. The risk of second cancers, especially for those with a genetic risk, will also be discussed along with the risks of other health conditions that can come with treatment for gyn cancers. We will finish our chat discussing the impact of Covid19 infection and other illnesses among women with a gyn cancer, including mental health issues.

We will use the following Topic Questions (T:) to guide our discussion:

T1: What is the risk of recurrence for the main types of gynecologic cancer? Which gyn cancers have the highest recurrence risk?

T2: What is known about reducing one's risk of recurrence? How are cancer survivors monitored for gyn cancer recurrence?

T3: Many cancer survivors report that fear of recurrence impacts their survivorship. What are some tips for dealing with the fear of recurrence?

T4: What are some of the secondary cancers that those with a gynecologic cancer should be concerned about? What is the role of genetics and family history? What about secondary cancers related to treatment?

T5: Are there other physical and mental health conditions that being diagnosed with and treated for gynecologic cancers increase the risk of experiencing?

T6: What impact does having had cancer have on risk for and severity of COVID-19 and other non-cancer related diseases? 


We hope you can join us,

Dee and Christina



Wednesday, April 14, 2021

OCRA Community Partner

Since early in our history as a community for those impacted by gynecologic cancer, the #gyncsm community has been an Ovarian Cancer Research Alliance (OCRA) Community Partner. You can learn more about Community Partners here. 

We thought it important to share this What You Need to Know About Ovarian Cancer graphic with all of you.  Feel free to share with others. 

 


Just a reminder, there will be no #gyncsm chat this month. Save the date for our next chat Wednesday, May 12, 2021 at 8pmET (new time for 2021) when we’ll discuss “Cancer Survivors: Risk of Recurrence and Other Cancers/Diseases”.


Dee